IVD Test Reagent/Kits, Immunoassay, Autoimmune, Connective Tissue, Extractable Nuclear Antigen, Antibody

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine antibodies to extractable nuclear antigens (ENA). Increased ENA antibodies levels are associated with autoimmune connective-tissue diseases such as rheumatoid arthritis. ENA determination is a screening test.

Entry Terms : "Extractable Nuclear Antigen (ENA) Antibody Determination Reagents" , "ENA Antibody Screening Reagents" , "ENA Antibody Determination Reagents" , "ENA (Extractable Nuclear Antigen) Antibody Determination Reagents" , "Reagents, Antiextractable Nuclear Antigen" , "Reagents, Immunoassay, Autoimmune, Connective Tissue, Extractable Nuclear Antigen, Antibody"

UMDC code : 19176

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-5 of 5 Match(es).

GFMD Ltd

Company Type: Parent

Global Focus Marketing & Distribution Ltd. is a specialized sales organization, holding patent positions on leading edge diagnostics and equipment. We are dedicated to helping you prosper and survive the rigors of the 21st-century laboratory environment

Immuno Concepts NA Ltd

Company Type: Parent

Immuno Concepts was founded in 1979 with a commitment to advance the quality of diagnostic assays for systemic rheumatic diseases. Over thirty years later we still honor that commitment. Our company motto, "Quality People Setting the Quality Standard," further reflects this commitment. We are proud to display that we have a quality system that is certified to ISO 13485 and we currently have all of our products CE marked.

Innominata dba GenBio

Company Type: Parent

Formed in 1994, GenBio is an experienced, fully integrated medical diagnostic company focused on infectious disease and autoimmune disease diagnostics. GenBio develops, manufactures and markets extensive lines of infectious disease and autoimmunity serology products under U.S. FDA and ISO 13485 standards.

Mayo Medical Laboratories

Company Type: Parent

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-5 of 5 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone